TCIM
GNMX
TIAA CREF Investment Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-97,719
| Closed | -$182K | – | 3214 |
|
|
2017
Q1 | $182K | Buy |
97,719
+13,966
| +17% | +$26K | ﹤0.01% | 3006 |
|
|
2016
Q4 | $434K | Buy |
83,753
+2,727
| +3% | +$14.1K | ﹤0.01% | 2892 |
|
|
2016
Q3 | $451 | Hold |
81,026
| – | – | ﹤0.01% | 2887 |
|
|
2016
Q2 | $450K | Buy |
81,026
+19,246
| +31% | +$107K | ﹤0.01% | 2905 |
|
|
2016
Q1 | $272K | Sell |
61,780
-21,568
| -26% | -$95K | ﹤0.01% | 2931 |
|
|
2015
Q4 | $502K | Buy |
83,348
+30,700
| +58% | +$185K | ﹤0.01% | 2892 |
|
|
2015
Q3 | $412K | Hold |
52,648
| – | – | ﹤0.01% | 2944 |
|
|
2015
Q2 | $323K | Buy |
+52,648
| New | +$323K | ﹤0.01% | 3057 |
|